NMPA Approval

Dexmedetomidine Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20213576

Company成都倍特药业股份有限公司

Registration Date

July 12, 2021

Drug Information

Generic Name

盐酸右美托咪定氯化钠注射液

Dosage Form

注射剂

Strength

100ml︰盐酸右美托咪定0.4mg（按C13H16N2计）与氯化钠0.9g

Drug Type

化学药品

Registration Date

July 12, 2021

Company Information

Applicant Company

Company Name成都倍特药业股份有限公司

Company Address

成都高新区和祥三街263号

Manufacturing Company

Company Name成都倍特药业股份有限公司

Company Address

成都市双流西南航空港经济开发区空港四路1166号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸右美托咪定氯化钠注射液 - NMPA 批准文号 | MedPath